| Literature DB >> 30926249 |
David Balgoma1, Curt Pettersson2, Mikael Hedeland2.
Abstract
Recent studies have reported the upregulation of a subgroup of triacylglycerides as markers of different diseases with dysregulated lipogenesis, which means that these markers are not selective. This observation has a deep impact on their use as diagnostic tools in clinical practice (e.g., markers of risk of type 2 diabetes).Entities:
Keywords: disease markers; dysregulated lipogenesis; lipidomics; liver X receptors; regulatory element-binding transcription factors; triglycerides
Year: 2019 PMID: 30926249 DOI: 10.1016/j.tem.2019.02.008
Source DB: PubMed Journal: Trends Endocrinol Metab ISSN: 1043-2760 Impact factor: 12.015